Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores

[1]  A. Feinberg,et al.  Comprehensive High‐Throughput Arrays for Relative Methylation (CHARM) , 2010, Current protocols in human genetics.

[2]  O. Sieber,et al.  Putative direct and indirect Wnt targets identified through consistent gene expression changes in APC-mutant intestinal adenomas from humans and mice , 2008, Human molecular genetics.

[3]  A. Feinberg,et al.  SNP-specific array-based allele-specific expression analysis. , 2008, Genome research.

[4]  S. Orkin,et al.  Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage , 2008, The Journal of experimental medicine.

[5]  Jim Stalker,et al.  A Novel CpG Island Set Identifies Tissue-Specific Methylation at Developmental Gene Loci , 2008, PLoS biology.

[6]  Kenta Nakai,et al.  DBTSS: database of transcription start sites, progress report 2008 , 2007, Nucleic Acids Res..

[7]  John M. Greally,et al.  CG dinucleotide clustering is a species-specific property of the genome , 2007, Nucleic acids research.

[8]  Li Zhang,et al.  Genome-Wide Profiling of DNA Methylation Reveals a Class of Normally Methylated CpG Island Promoters , 2007, PLoS genetics.

[9]  Robert Brown,et al.  Inactivation of HOXA Genes by Hypermethylation in Myeloid and Lymphoid Malignancy is Frequent and Associated with Poor Prognosis , 2007, Clinical Cancer Research.

[10]  Ivo G Gut,et al.  DNA methylation analysis by pyrosequencing , 2007, Nature Protocols.

[11]  K. Aldape,et al.  Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth , 2007, Proceedings of the National Academy of Sciences.

[12]  Michael B. Stadler,et al.  Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome , 2007, Nature Genetics.

[13]  R. Spang,et al.  Gene Expression Signatures for Tumor Progression, Tumor Subtype, and Tumor Thickness in Laser-Microdissected Melanoma Tissues , 2007, Clinical Cancer Research.

[14]  J. Rogers,et al.  DNA methylation profiling of human chromosomes 6, 20 and 22 , 2006, Nature Genetics.

[15]  Nazneen Rahman,et al.  Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles , 2006, Nature Genetics.

[16]  Shoshana J. Wodak,et al.  GenePro: a cytoscape plug-in for advanced visualization and analysis of interaction networks , 2006, Bioinform..

[17]  Sam Richman,et al.  An online database for brain disease research , 2006, BMC Genomics.

[18]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[19]  James B. Mitchell,et al.  Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. , 2004, Cancer cell.

[20]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[21]  A. Feinberg,et al.  The history of cancer epigenetics , 2004, Nature Reviews Cancer.

[22]  J. Kawai,et al.  Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  John D. Storey.  The positive false discovery rate: a Bayesian interpretation and the q-value , 2003 .

[24]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[25]  Terence P. Speed,et al.  A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..

[26]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[27]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[28]  John D. Storey,et al.  Empirical Bayes Analysis of a Microarray Experiment , 2001 .

[29]  N. Miller,et al.  Frequent loss of imprinting of PEG1/MEST in invasive breast cancer. , 1999, Cancer research.

[30]  Francisco Antequera,et al.  CpG islands as genomic footprints of promoters that are associated with replication origins , 1999, Current Biology.

[31]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.

[32]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[33]  Garrison Fh,et al.  [History of cancer]. , 1926, Il Policlinico. Sezione pratica.

[34]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[35]  John Suckling,et al.  Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain , 1999, IEEE Transactions on Medical Imaging.

[36]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .